10 reports

In Prevention, the QuantiFERON-TB test for detection of latent Tuberculosis (TB) grew more than ##% CER and represented approximately ##% of total sales.

  • Ovarian Cancer
  • World
  • Forecast
  • bioMerieux S.A.
  • Cepheid

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Ovarian Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Shenzhen Main Luck Pharmaceuticals Inc.

It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology.

  • Ovarian Cancer
  • China
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • Shenzhen Main Luck Pharmaceuticals Inc.

Deal Information Deal Status Completed Date Deal Product tuberculosis vaccine Companies Information Partner Company Information Company Name Business Description Completed ##-Feb-2012 Product Description Tuberculosis vaccine was under development.

  • Ovarian Cancer
  • Pharmaceutical
  • Vaccine
  • Company
  • Immunovaccine Inc.
  • APR 12, 2016: CELSION ANNOUNCES UPCOMING PRESENTATION AT AACR 2016 HIGHLIGHTING POTENTIAL OF GEN-1 IL-12 IMMUNOTHERAPY IN OVARIAN CANCER

The company' s project pipeline includes products with therapeutic application in the area of diabetes type II, leishmaniasis, and tuberculosis.

  • Biosimilar
  • Monoclonal Antibody
  • Ovarian Cancer
  • Therapy
  • OncoSec Medical Incorporated
  • Ayanda Biosystems S.A. Pipeline Products by Indication
  • Ayanda Biosystems S.A. Pipeline Products Summary by Development Stage
  • Ovarian Cancer
  • Switzerland
  • Company
  • Product Initiative
  • BioSystems, S.A.
  • EPITHELIAL OVARIAN CANCER - PIPELINE BY SANOFI PASTEUR SA, H1 2016

The drug candidate was also tested in in-vivo mouse model for tuberculosis.

  • Monoclonal Antibody
  • Ovarian Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • CLINICAL TRIAL PROFILE. 1545 TRIAL TITLE

Ovarian Cancer Global Clinical Trials Review, H##, 2016 REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: MAY 2016 LIST OF TABLES LIST OF FIGURES OVARIAN CANCER GLOBAL CLINICAL TRIALS REVIEW, H##, 2016 OUTLINES CLINICAL TRIALS IN OVARIAN CANCER.

  • Clinical Trial
  • Drug Discovery And Development
  • Ovarian Cancer
  • World
  • Product Initiative
  • EPITHELIAL OVARIAN CANCER - PIPELINE BY SANOFI PASTEUR SA, H2 2016
  • EPITHELIAL OVARIAN CANCER - PIPELINE BY INNATE IMMUNOTHERAPEUTICS LTD, H2 2016

The drug candidate was also tested in in-vivo mouse model for tuberculosis.

  • Ovarian Cancer
  • United States
  • Company
  • Product Initiative
  • Merck & Co., Inc.
  • BIRINAPANT - DRUG PROFILE PRODUCT DESCRIPTION

The drug candidate was also tested in in-vivo mouse model for tuberculosis.

  • Cancer
  • Ovarian Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.